nasdaq-mynz-mainzbiomed.png
Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test
November 09, 2023 08:01 ET | Mainz BioMed NV
Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test
nasdaq-mynz-mainzbiomed.png
Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA
November 07, 2023 08:01 ET | Mainz BioMed NV
Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-Kipper
October 31, 2023 08:01 ET | Mainz BioMed NV
Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-Kipper
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations
October 26, 2023 08:01 ET | Mainz BioMed NV
Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Presents Groundbreaking Results of ColoFuture Study
October 18, 2023 08:01 ET | Mainz BioMed NV
Mainz Biomed Presents Groundbreaking Results of ColoFuture Study
nasdaq-mynz-mainzbiomed.png
Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark
October 11, 2023 08:01 ET | Mainz BioMed NV
Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark
nasdaq-mynz-mainzbiomed.png
Mainz Biomed to Attend the JonesTrading 2023 Healthcare Summit 
October 05, 2023 08:01 ET | Mainz BioMed NV
Mainz Biomed to Attend the JonesTrading 2023 Healthcare Summit
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Announces Live Launch of ColoAlert® with Bioclinica in Romania
October 04, 2023 08:01 ET | Mainz BioMed NV
Mainz Biomed Announces Live Launch of ColoAlert® with Bioclinica in Romania
nasdaq-mynz-mainzbiomed.png
Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology
September 27, 2023 08:01 ET | Mainz BioMed NV
Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology
nasdaq-mynz-mainzbiomed.png
Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference 
September 20, 2023 03:01 ET | Mainz BioMed NV
BERKELEY, Calif. and MAINZ, Germany, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the...